Stock Region Penny Picks
Stock Region Penny Picks Watchlist Newsletter - Monday, October 28th, 2024.
Stock Region Penny Picks Watchlist Newsletter - Monday, October 28th, 2024
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: This newsletter is for informational purposes only and does not constitute financial advice. Please conduct your own research or consult with a financial advisor before making investment decisions.
Comprehensive Stock Highlights
DBV Technologies ($DBVT): HC Wainwright & Co. maintains a "Buy" rating and raises the price target to $7, indicating strong growth potential.
Rivian ($RIVN): Partners with Patagonia and Sol Systems to advance renewable energy projects in Stokes County, NC, supporting sustainability initiatives.
Nxu ($NXU): Experiences a 166% increase to .6658, driven by its proposed merger with Verde Bioresins, generating high trading volume at 241M shares.
Monopar ($MNPR): Announces a collaboration with Alexion, AstraZeneca Rare Disease to develop a late-stage Wilson Disease drug candidate.
Jeffs' Brands ($JFBR): Granted an extension by NASDAQ to comply with the minimum bid price requirement, providing temporary relief.
Lyell Immunopharma ($LYEL): Pursues the acquisition of ImmPACT Bio and shifts focus to next-generation CAR T-cell therapies.
Benevolent ($BENF): Files for withdrawal of their registration statement, indicating a strategic reassessment.
Yoshitsu Co., Ltd ($TKLF): Signs a significant five-year agreement with Saynoday Limited to expand its "Reiwatakiya" brand across Hong Kong and Asia, including a $64.3M procurement plan and five new stores by 2027.
Evolv Technology ($ELAB): Gains attention on repeated news; caution advised due to potential market hype.
Brenmiller Energy ($BNRG): Collaborates with Entelios to enhance sustainable energy practices in Germany, aiming at a $2.9 billion market by 2028.
Avalon GloboCare ($ALBT): Partners with Qi Diagnostics to co-develop a real-time cannabis breathalyzer to address impaired driving.
Upexi ($UPXI): Plans to counteract stock manipulation with a reverse stock split, aiming to stabilize share performance.
Elray Resources ($ATNF): Announces the strategic sale of its crypto iGaming technology.
TCBP ($TCBP): Refutes false social media claims about delisting risks, defending its NASDAQ listing status.
Iterum Therapeutics ($ITRM): Receives FDA approval for ORLYNVAH, enhancing treatment options for urinary tract infections.
Oriental Moon Tree Limited ($GSIW): Files a 13D for a 65.32% stake in the company, showcasing significant ownership.
MIRA Pharmaceuticals ($MIRA): Reports Ketamir-2 exceeds current neuropathic pain treatments in efficacy, signaling potential market disruption.
MEI Pharma ($MEIP): Completes asset sale to Aardvark Therapeutics, marking a strategic divestment.
Healthcare Triangle ($HCTI): Acquires cloud and technology assets from SecureKloud Technologies, boosting tech domain capabilities.
Monte Rosa Therapeutics ($GLUE): Secures a global license agreement with Novartis to advance molecular glue degraders.
Evoke Pharma ($EVOK): Announces significant patient outcomes for GLP-1 users with diabetic gastroparesis.
ImmunoPrecise ($IPA): Advances anti-aging research in collaboration with Mayo Clinic, targeting an $81 billion market with AI technology.
Nexalin Technology ($NXL): Reports new data confirming cognitive benefits of its implantable device for Alzheimer's patients.
Autonomix ($AMIX): Demonstrates reduced opioid use with RF ablation technology in ongoing clinical trials.
Actelis Networks ($ASNS): Secures an order to modernize IoT networks for secure critical infrastructure in Germany.
Nature's Miracle Holding ($NMHI): Announces a deal with Robostreet to launch mobile E Farms in California, with 150 electric trucks expected.
Pineapple Subsidiary SUNation ($PEGY): Forms a partnership with Radial Power to expand renewable energy solutions.
Global Mofy's Gausspeed ($GMM): Invited to the NVIDIA Forum to showcase generative AI-powered visual experiences.
Shuttle Pharma ($SHPH): Completes clinical trial enrollment for Ropidoxuridine in treating glioblastoma.
Cemtrex ($CETX): Granted NASDAQ extension to rectify stockholder equity requirements.
Inspirato ($ISPO): Reports improved third-quarter financials post-reorganization, focusing on efficiency and cost savings.
American Rebel Holdings ($AREB): Introduces two new SAFE GUARD® models, expanding its product line.
Iterum Therapeutics ($ITRM): Gains traction with FDA approval for ORLYNVAH, a treatment for uncomplicated urinary tract infections.
Benevolent ($BENF): Requests withdrawal of its S-1 registration, indicating strategic changes.
Disclaimer: This newsletter is for informational purposes only and does not constitute financial advice. Please conduct your own research or consult with a financial advisor before making investment decisions.
We are working endlessly to provide free insights on the stock market every day, and greatly appreciate those who are paid members supporting the development of the Stock Region mobile application. Stock Region offers daily stock and option signals, watchlists, earnings reports, technical and fundamental analysis reports, virtual meetings, learning opportunities, analyst upgrades and downgrades, catalyst reports, in-person events, and access to our private network of investors for paid members as an addition to being an early investor in Stock Region. We recommend all readers to urgently activate their membership before reaching full member capacity (500) to be eligible for the upcoming revenue distribution program. Memberships now available at https://stockregion.net